Baldapan, Joana .
HRN: 23-58-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2023
MUPIROCIN 2%, 15G (TUBE)
09/08/2023
09/14/2023
TOPICAL
2%
BID
Post Iv Site Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes